Literature DB >> 29653750

Induced pluripotent stem cells with NOTCH1 gene mutation show impaired differentiation into smooth muscle and endothelial cells: Implications for bicuspid aortic valve-related aortopathy.

Jiao Jiao1, Weihua Tian1, Ping Qiu1, Elizabeth L Norton1, Michael M Wang2, Y Eugene Chen1, Bo Yang3.   

Abstract

OBJECTIVE: The NOTCH1 gene mutation has been identified in bicuspid aortic valve patients. We developed an in vitro model with human induced pluripotent stem cells (iPSCs) to evaluate the role of NOTCH1 in smooth muscle and endothelial cell (EC) differentiation.
METHODS: The iPSCs were derived from a patient with a normal tricuspid aortic valve and aorta. The NOTCH1 gene was targeted in iPSCs with the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 nuclease (Cas9) system. The NOTCH1-/- (NOTCH1 homozygous knockout) and isogenic control iPSCs (wild type) were differentiated into neural crest stem cells (NCSCs) and into cardiovascular progenitor cells (CVPCs). The NCSCs were differentiated into smooth muscle cells (SMCs). The CVPCs were differentiated into ECs. The differentiations of SMCs and ECs were compared between NOTCH1-/- and wild type cells.
RESULTS: The expression of NCSC markers (SRY-related HMG-box 10 and transcription factor AP-2 alpha) was significantly lower in NOTCH1-/-NCSCs than in wild type NCSCs. The SMCs derived from NOTCH1-/- NCSCs showed immature morphology with smaller size and decreased expression of all SMC-specific contractile proteins. In NOTCH1-/-CVPCs, the expression of ISL1, NKX2.5, and MYOCD was significantly lower than that in isogenic control CVPCs, indicating impaired differentiation from iPSCs to CVPCs. The NOTCH1-/-ECs derived from CVPCs showed significantly lower expression of cluster of differentiation 105 and cluster of differentiation 31 mRNA and protein, indicating a defective differentiation process.
CONCLUSIONS: NOTCH1 is critical in SMC and EC differentiation of iPSCs through NCSCs and CVPCs, respectively. NOTCH1 gene mutations might potentially contribute to the development of thoracic aortic aneurysms by affecting SMC differentiation in some patients with bicuspid aortic valve.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NOTCH1; bicuspid aortic valve; induced pluripotent stem cells; smooth muscle cells; thoracic aortic aneurysm

Mesh:

Substances:

Year:  2018        PMID: 29653750     DOI: 10.1016/j.jtcvs.2018.02.087

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   6.439


  11 in total

1.  Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 1: Pluridisciplinary perspective on their hemodynamics and morphomechanics.

Authors:  Ares Pasipoularides
Journal:  J Mol Cell Cardiol       Date:  2019-05-28       Impact factor: 5.000

Review 2.  HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction.

Authors:  Ampadu O Jackson; Huifang Tang; Kai Yin
Journal:  J Cardiovasc Transl Res       Date:  2019-05-31       Impact factor: 4.132

3.  In Vitro Lineage-Specific Differentiation of Vascular Smooth Muscle Cells in Response to SMAD3 Deficiency: Implications for SMAD3-Related Thoracic Aortic Aneurysm.

Authors:  Jian Gong; Dong Zhou; Longtan Jiang; Ping Qiu; Dianna M Milewicz; Y Eugene Chen; Bo Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-14       Impact factor: 8.311

Review 4.  Translational potential of hiPSCs in predictive modeling of heart development and disease.

Authors:  Corrin Mansfield; Ming-Tao Zhao; Madhumita Basu
Journal:  Birth Defects Res       Date:  2022-03-09       Impact factor: 2.661

5.  Differences in metabolic profiles between bicuspid and tricuspid aortic stenosis in the setting of transcatheter aortic valve replacement.

Authors:  Tian-Yuan Xiong; Chang Liu; Yan-Biao Liao; Wen Zheng; Yi-Jian Li; Xi Li; Yuanweixiang Ou; Zi-Jie Wang; Xi Wang; Chang-Ming Li; Zhen-Gang Zhao; Yuan Feng; Xiao-Jing Liu; Mao Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-05-18       Impact factor: 2.298

Review 6.  CRISPR/Cas system: An emerging technology in stem cell research.

Authors:  Maria Teresa Valenti; Michela Serena; Luca Dalle Carbonare; Donato Zipeto
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

7.  MiR-375-3p regulates rat pulmonary microvascular endothelial cell activity by targeting Notch1 during hypoxia.

Authors:  Yuan An; Ziquan Liu; Hui Ding; Qi Lv; Haojun Fan; Shike Hou; Wei Cai; Sanli Liu
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

8.  Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.

Authors:  Maximilian W Schenk; Sam Humphrey; A S Md Mukarram Hossain; Mitchell Revill; Sarah Pearsall; Alice Lallo; Stewart Brown; Samuel Bratt; Melanie Galvin; Tine Descamps; Cong Zhou; Simon P Pearce; Lynsey Priest; Michelle Greenhalgh; Anshuman Chaturvedi; Alastair Kerr; Fiona Blackhall; Caroline Dive; Kristopher K Frese
Journal:  Nat Commun       Date:  2021-11-17       Impact factor: 14.919

9.  Commentary: In the absence of convincing evidence, more is not better.

Authors:  Matheus P Falasa; George J Arnaoutakis; Thomas M Beaver
Journal:  JTCVS Open       Date:  2020-12-31

Review 10.  Modeling aortic diseases using induced pluripotent stem cells.

Authors:  Kai Zhu; Wenrui Ma; Jun Li; Yu Shrike Zhang; Weijia Zhang; Hao Lai; Chunsheng Wang
Journal:  Stem Cells Transl Med       Date:  2020-11-12       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.